Jan Åhlén

Prognostic Impact of Immunohistochemical Expression of Ezrin in Highly Malignant Soft Tissue Sarcomas

Wen‐Hui Weng, Jan Åhlén, Kristina Åström et al. · Clinical Cancer Research · 2005 · 110 citations · Full text

Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma

Jan Åhlén, Johan Wejde, Otte Brosjö et al. · Clinical Cancer Research · 2005 · 64 citations · Full text

Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones

Jan Åhlén, S. Andersson, Hitoshi Mukohyama et al. · Bone · 2002 · 57 citations

Inflammation, Bone Disease, Bone-resorptive Effect +9

microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome

Pınar Akçakaya, Stefano Caramuta, Jan Åhlén et al. · British Journal of Cancer · 2014 · 54 citations · Full text

miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors

Wen‐Kuan Huang, Pınar Akçakaya, Anastasia Gangaev et al. · Experimental Cell Research · 2018 · 44 citations · Full text

Imatinib Resistance, Tumor Biology, Mir-125a-5p Regulation +15